PROJECT INFORMATION | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GOLD Project ID
![]() |
Gp0550527
|
||||||||||||||||||||||||||||||
Project Name
![]() |
Campylobacter coli FDAARGOS_1028
|
||||||||||||||||||||||||||||||
Other Names
![]() |
|
||||||||||||||||||||||||||||||
Legacy GOLD ID
![]() |
|
||||||||||||||||||||||||||||||
NCBI BioProject Name |
|
||||||||||||||||||||||||||||||
NCBI BioProject Accession
![]() |
PRJNA231221 |
||||||||||||||||||||||||||||||
NCBI Locus Tag
![]() |
I6H85
|
||||||||||||||||||||||||||||||
NCBI BioSample Accession
![]() |
SAMN16357197 |
||||||||||||||||||||||||||||||
PI | |||||||||||||||||||||||||||||||
Added By |
JGI automated process
on 2021-03-12 |
||||||||||||||||||||||||||||||
Last Modified By |
JGI automated process
on 2021-03-19 |
||||||||||||||||||||||||||||||
Project Comments |
|
||||||||||||||||||||||||||||||
Project Status
![]() |
Complete and Published
|
||||||||||||||||||||||||||||||
Project Relevance
![]() |
Medical |
||||||||||||||||||||||||||||||
Sequencing Center
![]() |
U.S. Food and Drug Administration (FDA)
(USA)
Institute for Genome Sciences, University of Maryland School of Medicine (USA) |
||||||||||||||||||||||||||||||
Collaborating Institute
![]() |
|
||||||||||||||||||||||||||||||
Funding Agency
![]() |
|
||||||||||||||||||||||||||||||
Project Description
![]() |
Campylobacter coli FDAARGOS_1028 genome sequencing
|
||||||||||||||||||||||||||||||
Is JGI Project |
No
|
||||||||||||||||||||||||||||||
Project Information Visibility
![]() |
Public | ||||||||||||||||||||||||||||||
PROJECT TYPE | |||||||||||||||||||||||||||||||
Specimen
![]() |
Organism |
||||||||||||||||||||||||||||||
Nucleic Acid
![]() |
DNA |
||||||||||||||||||||||||||||||
Sequencing Strategy
![]() |
Whole Genome Sequencing
|
||||||||||||||||||||||||||||||
EXTERNAL PROJECT LINKS | |||||||||||||||||||||||||||||||
JGI Data Utilization Status
![]() |
|
||||||||||||||||||||||||||||||
JGI Award DOI
![]() |
|
||||||||||||||||||||||||||||||
Genome Publications
![]() |
|
||||||||||||||||||||||||||||||
Other Publications
![]() |
|
||||||||||||||||||||||||||||||
Ignored Publications
![]() |
|
||||||||||||||||||||||||||||||
Unassigned Publications
![]() |
Nature communications
10(1):3313
FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science.
|
||||||||||||||||||||||||||||||
SRA Experiment |
|
||||||||||||||||||||||||||||||
PROJECT COMPOSITION | |||||||||||||||||||||||||||||||
Study |
Genome sequencing as part of FDA-ARGOS: dAtabase for Regulatory Grade micrObial Sequences project |
||||||||||||||||||||||||||||||
Organism |
Campylobacter coli FDAARGOS_1028 |
||||||||||||||||||||||||||||||
Analysis Projects |
Campylobacter coli FDAARGOS_1028 |
||||||||||||||||||||||||||||||
Number of Analysis Projects (AP) |
1 |
||||||||||||||||||||||||||||||
Number of Derived Analyis Projects (DAP) |
0
|
SEQUENCING INFORMATION | |
---|---|
Sequencing Status
![]() |
Complete |
Sequencing Quality (MIGS-31) |
Level 6: Finished |
Finishing Goal
![]() |
|
Contamination Screening Input
![]() |
|
DNA Amplification Method
![]() |
|
Single Cell Lysis Protocol
![]() |
|
Single Cell Lysis Approach
![]() |
|
Sequencing Comments
![]() |
|
DNA Amplification Kit
![]() |
|
Sequencing Technology
(MIGS-29)
![]() |
Illumina Pacbio |
Library Method
(MIGS-28)
![]() |
|
Library Layout
![]() |
|
Library Screening Method
![]() |
|
Number Of Reads
![]() |
|
Read Size
![]() |
|
Vector
![]() |
|
GC Percent |
|
Chromosome Count |
|
Plasmid Count |
|
ORGANISM NAME | |
---|---|
GOLD Organism ID |
Go0575798 |
Organism Name |
Campylobacter coli FDAARGOS_1028
|
Other names (alias, synonyms, short names, common names) |
|
Organism Domain |
BACTERIAL
|
Phylogeny |
PROTEOBACTERIA-EPSILON
|
Genus |
Campylobacter
|
Genus Synonyms |
|
Species |
Campylobacter coli
|
Subspecies |
|
Species Synonyms |
|
Strain |
FDAARGOS_1028
|
Strain Synonyms |
|
Serovar/Cultivar |
|
Culture Collection ID |
ATCC BAA-1061D-5
|
Type Strain |
|
Exemplar DOI |
|
Exemplar Name |
|
Taxon DOI |
|
Biosafety Level |
|
Organism Comments |
|
Cultured |
Yes
|
Culture Type |
Isolate
|
Organism Type |
Natural
|
Uncultured Type |
|
Commercial Strain |
|
Commercial Strain Comments |
|
ORGANISM TAXONOMY
![]() |
|
NCBI Taxonomy ID |
195 |
NCBI Superkingdom |
Bacteria
|
NCBI Kingdom |
|
NCBI Phylum |
Proteobacteria
|
NCBI Class |
Epsilonproteobacteria
|
NCBI Order |
Campylobacterales
|
NCBI Family |
Campylobacteraceae
|
NCBI Genus |
Campylobacter
|
NCBI Species |
Campylobacter coli
|
ISOLATION CLASSIFICATION | |
Ecosystem |
|
Ecosystem Category |
|
Ecosystem Type |
|
Ecosystem Subtype |
|
Specific Ecosystem |
|
ORGANISM EXTERNAL REFERENCES | |
Strain Info ID |
|
Genbank 16S ID |
|
GENERAL PROPERTIES | |
---|---|
Oxygen Requirement |
|
Cell Shape |
|
Motility |
|
Sporulation |
|
Temperature Range |
|
Salinity |
|
pH |
|
Cell Diameter |
|
Cell Length |
|
Color |
|
Gram Staining |
|
Biotic Relationships |
|
Symbiotic Physical Interaction |
|
Symbiotic Relationship |
|
Symbiont Name |
|
Symbiont Taxon ID |
|
Cell Arrangements |
|
Diseases |
|
Known Habitats |
|
Metabolisms |
|
Phenotypes |
|
Energy Sources |
|
You are going to add the following user to your project, biosample and study.
Contact Name/Email: Do you want to continue?
You are going to remove permissions for the following user to your project, biosample and study.
Contact Name/Email: Do you want to continue?
Changing the SP visibility will also change visibility on the following items:
Do you want to continue with this visibility change?
Checking that this Sequencing Project can be made private:
Do you want to continue with this visibility change?
Changing the SP Sequencing Strategy will also effect these items:
Do you want to continue with this Sequencing Strategy change?